The DEEP project has received research funding from the European Union under the 7th Framework Programme

News

DEEP-3 study results published in the January issue of Haematologica

Febbraio 12, 2018
|
Comments off
|

Sebastian Botzenhardt from University Hospital of Erlangen and his co-writers have just published the results of the DEEP-3 study in the January issue of Haematologica on behalf of the DEEP consortium.

DEEP (Deferiprone Evaluation in Paediatrics) is funded EU-funded project aimed to investigate safety and […]

Share
Read more →

The pilot study QuBo was presented at the 14th International Conference on Thalassaemia & Haemoglobinopathies and 16th TIF International Conference for Patients & Parents

Febbraio 5, 2018
|
Comments off
|

From November 17th to 19th, 2017, the 14th International Conference on Thalassaemia & Haemoglobinopathies and the 16th TIF International Conference for Patients & Parents took place in Thessaloniki, Greece. In this occasion, the poster of the DEEP (DEferiprone Evaluation in Paediatrics) project discussing the DEEP-2 study informative […]

Share
Read more →

DEEP supports the Rare Disease Day 2018

Gennaio 29, 2018
|
Comments off
|

DEEP project is glad to support The Rare Disease Day 2018, that will take place on the last day of February 28th, to raise awareness of rare diseases and their impact on patients’ lives amongst the general public and decision-makers. The Rare Disease Day was first launched […]

Share
Read more →

Pubblication on “Pattern of complications and burden of disease in patients affected by beta thalassemia major”

Agosto 2, 2017
|
Comments off
|

Despite the correct application of blood transfusions and chelation treatments, beta thalassemia patients have many complications. Systematic population analyses on types and frequency of these complications are very few.

An article entitled “Pattern of complications and burden of disease in patients affected by beta thalassemia major” has now […]

Share
Read more →